Manulife (Manufacturers Life Insurance)
GSK icon

Manulife (Manufacturers Life Insurance)’s GSK GSK Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99M Sell
1,887,739
-490,337
-21% -$25.9M 0.08% 250
2026
Q1 		$131M Sell
2,378,076
-1,293,173
-35% -$70.1M 0.11% 180
2025
Q4 		$180M Sell
3,671,249
-404,339
-10% -$18.9M 0.15% 135
2025
Q3 		$176M Sell
4,075,588
-123,240
-3% -$4.81M 0.14% 144
2025
Q2 		$161M Buy
4,198,828
+3,080,734
+276% +$118M 0.14% 147
2025
Q1 		$43.3M Sell
1,118,094
-200,705
-15% -$7.35M 0.04% 378
2024
Q4 		$44.6M Buy
1,318,799
+300,310
+29% +$10.8M 0.04% 388
2024
Q3 		$41.6M Buy
1,018,489
+7,990
+0.8% +$327K 0.04% 409
2024
Q2 		$38.9M Buy
1,010,499
+1,053
+0.1% +$44.3K 0.04% 406
2024
Q1 		$43.3M Sell
1,009,446
-22,221
-2% -$916K 0.04% 376
2023
Q4 		$38.2M Buy
1,031,667
+41,632
+4% +$1.49M 0.02% 425
2023
Q3 		$35.9M Buy
990,035
+18,765
+2% +$666K 0.02% 411
2023
Q2 		$34.6M Buy
971,270
+206,424
+27% +$7.4M 0.02% 421
2023
Q1 		$27.2M Buy
764,846
+210,942
+38% +$7.38M 0.02% 509
2022
Q4 		$19.5M Sell
553,904
-36,359
-6% -$1.21M 0.01% 589
2022
Q3 		$17.4M Sell
590,263
-9,571
-2% -$363K 0.01% 629
2022
Q2 		$32.6M Buy
599,834
+3,067
+0.5% +$169K 0.02% 431
2022
Q1 		$32.5M Sell
596,767
-108,200
-15% -$5.88M 0.02% 483
2021
Q4 		$38.9K Hold
704,967
– – 0.02% 436
2021
Q3 		$33.7M Buy
704,967
+381,004
+118% +$19.1M 0.03% 470
2021
Q2 		$16.1M Buy
+323,963
New +$15.6M 0.01% 770
2018
Q4 		– Sell
-6,266
Closed -$315K – 2627
2018
Q3 		$315K Sell
6,266
-5,433
-46% -$276K ﹤0.01% 2526
2018
Q2 		$589K Sell
11,699
-123
-1% -$6.2K ﹤0.01% 2257
2018
Q1 		$577K Sell
11,822
-3,940
-25% -$183K ﹤0.01% 2232
2017
Q4 		$699K Sell
15,762
-544
-3% -$25.1K ﹤0.01% 2093
2017
Q3 		$828K Buy
16,306
+1,138
+8% +$57.7K ﹤0.01% 1929
2017
Q2 		$818K Buy
15,168
+2,374
+19% +$127K ﹤0.01% 1927
2017
Q1 		$674K Buy
12,794
+579
+5% +$29.4K ﹤0.01% 1982
2016
Q4 		$588K Buy
12,215
+1,102
+10% +$54.4K ﹤0.01% 1994
2016
Q3 		$599K Buy
11,113
+2,515
+29% +$138K ﹤0.01% 1962
2016
Q2 		$465K Buy
8,598
+2,573
+43% +$136K ﹤0.01% 2084
2016
Q1 		$306K Buy
6,025
+3,011
+100% +$150K ﹤0.01% 2298
2015
Q4 		$152 Buy
3,014
+1,688
+127% +$86K ﹤0.01% 2858
2015
Q3 		$63 Sell
1,326
-5,596
-81% -$291K ﹤0.01% 3279
2015
Q2 		$360 Sell
6,922
-286,605
-98% -$16.1M ﹤0.01% 2358
2015
Q1 		$16.9K Buy
293,527
+5,261
+2% +$302K 0.02% 489
2014
Q4 		$15.4K Buy
+288,266
New +$16.1M 0.02% 477
2013
Q3 		– Sell
-8,925
Closed -$557K – 3703
2013
Q2 		$557K Buy
+8,925
New +$566K ﹤0.01% 1817

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s GSK Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its GSK (GSK) stake by 21% in Q2 2026, selling an estimated $25.9M and leaving 1,887,739 shares worth $99M. The position accounts for 0.08% of the portfolio, ranked #250.

Manulife (Manufacturers Life Insurance) first reported a position in GSK in Q2 2013 and has held it in 38 quarters since. The position peaked at $180M in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 1,887,739 shares of GSK worth $99M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 490,337 GSK shares in Q2 2026, an estimated $25.9M.
  • GSK made up 0.08% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #250 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in GSK in Q2 2013 and has held it in 38 quarters since.
  • Manulife (Manufacturers Life Insurance)'s GSK position peaked at $180M in Q4 2025.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.